Association of CYP2C9, CYP2A6, ACSM2A, and CPT1A gene polymorphisms with adverse effects of valproic acid in Chinese patients with epilepsy
-
Add time:09/24/2019 Source:sciencedirect.com
ObjectiveTo explore the influence of CYP2C9, CYP2A6, ACSM2A, CPT1A gene polymorphisms on valproic acid (VPA) and its role in metabolism-related liver dysfunction in order to guide the clinical safety and rational use of VPA.
We also recommend Trading Suppliers and Manufacturers of 4-propyl-4-pentenoic acid (cas 13722-70-8). Pls Click Website Link as below: cas 13722-70-8 suppliers
Prev:Inhibition of medium-chain fatty acid β-oxidationinvitro by valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acid
Next:Pyruvate uptake is inhibited by valproic acid and metabolites in mitochondrial membranes) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- ArticlesStereoselective Synthesis of the Diunsaturated Metabolites of Valproic Acid09/27/2019
- Regular paperDetermination of valproic acid and its metabolites using gas chromatography with mass-selective detection: application to serum and urine samples from sheep09/26/2019
- Pyruvate uptake is inhibited by valproic acid and metabolites in mitochondrial membranes09/25/2019
- Inhibition of medium-chain fatty acid β-oxidationinvitro by valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acid09/10/2019
- Derivatization oriented strategy for enhanced detection of valproic acid and its metabolites in human plasma and detection of valproic acid induced reactive oxygen species associated protein modifications by mass spectrometry09/09/2019
- Asymmetric synthesis and enantioselective teratogenicity of 2-n-propyl-4-pentenoic acid (4-en-VPA), an active metabolite of the anticonvulsant drug, valproic acid09/08/2019
- Simultaneous determination of valproic acid and 2-propyl-4-pentenoic acid for the prediction of clinical adverse effects in Chinese patients with epilepsy09/07/2019
-
Health and Chemical more >